|
Mr. Peter Greenleaf was appointed MedImmune’s senior vice president marketing and sales in May 2006. In this role he is responsible for leading MedImmune’s global commercial organization and developing strategies to ensure the successful commercialization of the company’s current and future product portfolio. Mr. Greenleaf joins MedImmune from Centocor Inc. where he served as vice president of the Gastroenterology Franchise responsible for sales marketing strategic planning and business development. He joined Centocor’s cardiovascular division in 1998 and later moved into the immunology business holding a number of positions with increasing responsibility in sales and marketing. Previously he was employed in sales and marketing capacities with Boehringer Mannheim Corporation and US Healthcare Inc. Mr. Greenleaf holds a bachelor of science degree from Western Connecticut State University and a master’s degree in business administration from St. Joseph’s University. | 